Join us for ongoing discussions with our clinician-bloggers,
Paul Sax, MD
HIV and ID Observations
An ongoing dialogue on HIV/AIDS, infectious diseases,
all matters medical, and some not so medical
Recent Posts
End-of-Summer Musings — Hepatitis B, Dalbavancin, Alpha-Gal, and More • September 4, 2025
The last time I did one of these quick “musings” posts, I listed 21, and someone asked me, “Why 21?” The answer — obviously — is that I originally planned on writing 20, but then had to add a 21st, just because that’s exactly how many points you need to win a ping pong game. […]
2021-2022
Chief Resident Panel:
Abdullah Al‑abcha, MD
Mikita Arora, MD
Madiha Khan, DO
Mikita Arora, MD
Khalid A. Shalaby, MBBCh
Brandon Temte, DO
Insights on Residency Training
Notes from chief residents in family and internal medicine
Recent Posts
Developing Resident Educators • August 19, 2022 • Brandon Temte, DO
We currently find ourselves at the start of another academic year. By this time in August, many medical trainees are settling into new roles. Recently graduated medical students are getting used to hearing Dr. before their name. New senior residents who were interns a short time ago now find themselves leaders of their own teams. […]
Follow us on:
Apple Podcasts
YouTube
Spotify
Clinical Conversations
This podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.
Recent Posts
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 • September 2, 2022
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote […]
The post Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 first appeared on Clinical Conversations.Statements and opinions expressed in these blogs reflect the views of the author(s) and not necessarily the official policy of NEJM Journal Watch, NEJM Group, or the Massachusetts Medical Society, unless so stated.
NEJM Journal Watch — Recent Infectious Diseases Articles- Observations from ID and Beyond: End-of-Summer Musings — Hepatitis B, Dalbavancin, Alpha-Gal, and More
- Immunocompromised with Pneumonia: Are Broad-Spectrum Antibiotics Required?
- Can Oral Microbiome Therapy Break the Cycle of Recurrent Clostridioides difficile Infection?
- Observations from ID and Beyond: Watching the Chaos at the CDC — with Sadness and Alarm
- Dalbavancin in the Treatment of Staphylococcus aureus Bacteremia
- NEJM Journal Watch — Recent General Medicine Articles
- Observations from ID and Beyond: End-of-Summer Musings — Hepatitis B, Dalbavancin, Alpha-Gal, and More
- Don't Overlook Degenerative Cervical Myelopathy in Patients with Upper and Lower Extremity Symptoms
- Immunocompromised with Pneumonia: Are Broad-Spectrum Antibiotics Required?
- Early Sepsis Treatment — Are We Reaching for the Wrong Antibiotics?
- Raising Potassium to a High-Normal Level Benefits Patients with an ICD